BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Biomolecules | Free Full-Text | Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Frontiers | Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | Scientific Reports
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors | Nature Reviews Drug Discovery
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer | Cell Death & Disease
Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/5-Figure2-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
PDF) Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy - Frontiers
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/3-Table2-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/4-Table3-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
Bcl-2 - an overview | ScienceDirect Topics
YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression | Cell Death & Disease
